Neurology
RSSArticles
-
ß-Blockers Build Better Bones
Use of ß-blockers is associated with reduced risk of fracture. The magnitude of reduction is similar to that seen with use of thiazides. -
Full October 29, 2004, Issue in PDF
-
Clinical Briefs
Toenail Chromium in Men With Diabetes and Cardiovascular Disease; Combination of Fenofibrate and Rosiglitazone and HDL Cholesterol; Outcomes for Patients with Diet-Controlled Diabetes -
Pharmacology Update: Abacavir Sulfate and Lamivudine Tablets (Epzicom)
The FDA has approved a combination of 2 antiretrovirals, abacavir and lamivudine for the treatment of HIV-1 infections. -
Relationship Between Calcium Scans and Stress Myocardial Perfusion
A calcium score < 100 eliminates the need for MPS, but patients with a negative MPS often have coronary calcium. These findings imply a potential role for applying CAC screening after MPS among patients manifesting normal MPS. -
Coronary Heart Disease and Anemia: To Transfuse or Not?
A retrospective study of 24,112 patients with coronary heart disease showed increased 30-day mortality in patients who received one or more blood transfusions for anemia compared to comparable patients not transfused. -
Pharmacology Watch: The FDA and Merck Fielding Concerns About Vioxx
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market. -
Neuropathy in Neurofibromatosis
Peripheral neuropathy in NF-1 patients is a marker for poorer prognosis and mandates heightened vigilance for malignancy and spinal cord complications. -
A Major Advance in CT Angiography, Volumetric Computed Tomography (VCT)
VCT substantially improves imaging of vascularization in tumors and offers a promising tool for preclinical studies of tumor angiogenesis and antiangiogenic therapies. -
Full November 2004 Issue in PDF